Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05217160 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 1, 2022 (before its estimated May 31, 2022 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study is intended to provide information from subjects who currently have painful, chronically open wounds and assess the pain reduction capacity of KeraStat® Gel with Morphine. In gathering data from subjects who have baseline pain from their chronically open wounds, the investigators can then evaluate the capacity of KeraStat® Gel plus Morphine in reducing the subjects daily pain levels, pain associated with dressing changes, and pain medication consumption.
Trial Details
NCT Number NCT05217160
Lead Sponsor The Metis Foundation
Conditions
(from sponsor)		 Wound of Skin, Burns
Related terms Burns
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov